secwatch.observer — SEC 8-K summary
======================================

Issuer:     Owlet, Inc. (OWLT)
CIK:        0001816708
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001628280-23-025334
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Owlet appoints Melissa Gonzales to board; brings women's health and consumer healthcare expertise
--------------------------------------------------------------------------------

- Melissa Gonzales appointed as Class I director effective July 18, 2023, term expiring at 2025 annual meeting.
- Gonzales is President, Women's Health at Myriad Genetics (MYGN) and brings 20+ years healthcare experience.
- She will receive annual cash retainer of $50k and initial RSU grant valued ~$150k prorated.
- Owlet CEO cites Gonzales' expertise as key as company prepares to launch BabySat FDA-cleared pulse oximetry device.
- Gonzales also serves as Board Chair of March of Dimes, Chicago.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/0001628280-23-025334-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816708/000162828023025334/owlt-20230718.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-025334

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer